Longitude Capital Partners III, LLC - Insider Trading & Ownership

Location
800 El Camino, Suite 220, Menlo Park, CA
Summary
The estimated value of insider holdings of Longitude Capital Partners III, LLC is at least $70.1M dollars as of April 29, 2022. Longitude Capital Partners III, LLC is the 10%+ Owner of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $54.7M. Longitude Capital Partners III, LLC is the 10%+ Owner of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $14.9M. Longitude Capital Partners III, LLC is the 10%+ Owner of Sierra Oncology, Inc. and owns shares of Sierra Oncology, Inc. stock worth about $441K.
Signature
Longitude Venture Partners III, L.P.; By /s/ Patrick G. Enright, Managing Member of the general partner
All Insider Reports
All Insider Reports

Ownership of Longitude Capital Partners III, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRML Tourmaline Bio, Inc. 10%+ Owner $54.7M May 11, 2021
INZY Inozyme Pharma, Inc. 10%+ Owner $14.9M Apr 19, 2022
SRRA Sierra Oncology, Inc. 10%+ Owner $441K Apr 27, 2022

Insider Transactions Reported by Longitude Capital Partners III, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.